Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/EBITDA ratio high or low?
The EV/EBITDA ratio of 12.62x is 89% below its estimated 1-year average of 113.41x, near the low end of its estimated 1-year range (12.62x–194.50x).
As of 2026-10-06T22:12:32.104Z.
Calculation as of: 2026-10-06T22:12:32.104Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 295890ca45b9fb7c845dc9b7cfc12ce3e82df22f7cd737cbd4420fef5fb5231a
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
12.62x
EV/EBITDA RATIO AVG TTM
N/A
EV/EBITDA RATIO AVG 3Y
N/A
EV/EBITDA RATIO AVG 5Y
N/A
EV/EBITDA RATIO AVG 10Y
N/A
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
15.69x
median of 217 covered companies
CURRENT VS SECTOR MEDIAN
-19.57%
vs the sector median at left
Market Cap
$2.28B
EV/EBITDA Ratio
7.36x
TTM Avg
6.56x
3Y Avg
7.54x
5Y Avg
13.22x
Market Cap
$2.34B
EV/EBITDA Ratio
20.54x
TTM Avg
17.29x
3Y Avg
21.88x
5Y Avg
20.47x
Market Cap
$2.36B
EV/EBITDA Ratio
10.74x
TTM Avg
16.44x
3Y Avg
40.11x
5Y Avg
40.11x
Market Cap
$2.38B
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.43B
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Liquidia Corporation (LQDA) | $2.30B | 12.62x | N/A | N/A | N/A |
| Harmony Biosciences Holdings, Inc. (HRMY)vs › | $2.28B | 7.36x | 6.56x | 7.54x | 13.22x |
| UFP Technologies, Inc. (UFPT)vs › | $2.34B | 20.54x | 17.29x | 21.88x | 20.47x |
| Nurix Therapeutics, Inc. (NRIX)vs › | $2.35B | N/A | N/A | N/A | N/A |
| ADMA Biologics, Inc. (ADMA)vs › | $2.36B | 10.74x | 16.44x | 40.11x | 40.11x |
| Disc Medicine, Inc. (IRON)vs › | $2.37B | N/A | N/A | N/A | N/A |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.24B | N/A | N/A | N/A | N/A |
| Clover Health Investments, Corp. (CLOV)vs › | $2.38B | N/A | N/A | N/A | N/A |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.43B | N/A | N/A | N/A | N/A |
| Pharvaris N.V. (PHVS)vs › | $2.17B | N/A | N/A | N/A | N/A |
At 12.6, EV/EBITDA is at an extreme level, where the multiple carries little signal — higher than 0% of readings in its estimated 1-year history.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
estimated 1-year low
15.6
median
131.9
estimated 1-year high
194.5
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2026-10-05 | 15.55x |
| 2026-10-02 | 16.14x |
| 2026-10-01 | 15.76x |
| 2026-09-30 | 17.11x |
| 2026-09-29 | 41.19x |
| 2026-09-28 | 42.96x |
| 2026-09-25 | 39.84x |
| 2026-09-24 | 41.34x |
| 2026-09-23 | 39.28x |
| 2026-09-22 | 39.96x |
| 2026-09-21 | 38.65x |
| 2026-09-18 | 38.92x |
| 2026-09-17 | 39.82x |
| 2026-09-16 | 39.85x |
| 2026-09-15 | 38.23x |
| 2026-09-14 | 37.98x |
| 2026-09-11 | 38.83x |
| 2026-09-10 | 39.49x |
| 2026-09-09 | 40.25x |
| 2026-09-08 | 39.39x |
| 2026-09-04 | 39.98x |
| 2026-09-03 | 39.96x |
| 2026-09-02 | 40.58x |
| 2026-09-01 | 38.93x |
| 2026-08-31 | 39.68x |
| 2026-08-28 | 39.40x |
| 2026-08-27 | 40.74x |
| 2026-08-26 | 41.58x |
| 2026-08-25 | 41.07x |
| 2026-08-24 | 40.94x |
| 2026-08-21 | 39.95x |
| 2026-08-20 | 41.40x |
| 2026-08-19 | 43.95x |
| 2026-08-18 | 43.35x |
| 2026-08-17 | 45.36x |
| 2026-08-14 | 43.42x |
| 2026-08-13 | 42.02x |
| 2026-08-12 | 168.24x |
| 2026-08-11 | 188.11x |
| 2026-08-10 | 194.50x |
| 2026-08-07 | 192.76x |
| 2026-08-06 | 191.05x |
| 2026-08-05 | 190.40x |
| 2026-08-04 | 188.82x |
| 2026-08-03 | 179.10x |
| 2026-07-31 | 179.65x |
| 2026-07-30 | 185.43x |
| 2026-07-29 | 185.47x |
| 2026-07-28 | 185.47x |
| 2026-07-27 | 180.32x |
| 2026-07-24 | 184.18x |
| 2026-07-23 | 190.21x |
| 2026-07-22 | 185.94x |
| 2026-07-21 | 172.75x |
| 2026-07-20 | 164.57x |
| 2026-07-17 | 170.71x |
| 2026-07-16 | 160.69x |
| 2026-07-15 | 166.01x |
| 2026-07-14 | 163.31x |
| 2026-07-13 | 151.98x |
| 2026-07-10 | 166.40x |
| 2026-07-09 | 173.95x |
| 2026-07-08 | 169.70x |
| 2026-07-07 | 173.48x |
| 2026-07-06 | 169.14x |
| 2026-07-02 | 168.54x |
| 2026-07-01 | 169.38x |
| 2026-06-30 | 170.26x |
| 2026-06-29 | 160.37x |
| 2026-06-26 | 166.91x |
| 2026-06-25 | 164.23x |
| 2026-06-24 | 161.27x |
| 2026-06-23 | 158.05x |
| 2026-06-22 | 161.16x |
| 2026-06-18 | 151.68x |
| 2026-06-17 | 146.48x |
| 2026-06-16 | 145.11x |
| 2026-06-15 | 153.24x |
| 2026-06-12 | 152.02x |
| 2026-06-11 | 152.88x |
| 2026-06-10 | 139.19x |
| 2026-06-09 | 136.53x |
| 2026-06-08 | 136.29x |
| 2026-06-05 | 131.90x |
| 2026-06-04 | 133.38x |
| 2026-06-03 | 118.68x |
| 2026-06-02 | 117.43x |
| 2026-06-01 | 125.24x |
| 2026-05-29 | 131.92x |
| 2026-05-28 | 132.28x |
| 2026-05-27 | 132.28x |
| 2026-05-26 | 128.14x |
| 2026-05-22 | 130.03x |
| 2026-05-21 | 132.15x |
| 2026-05-20 | 131.72x |
| 2026-05-19 | 127.88x |
| 2026-05-18 | 121.42x |
| 2026-05-15 | 121.34x |
| 2026-05-14 | 126.42x |
| 2026-05-13 | 122.76x |
| 2026-05-12 | 120.63x |